04166nam a2200277 4500 392979 9291680060 392979 20150127d1997 y0pory50 ba eng Estimating the prevalence of problem drug use in Europe European Monitoring Centre for Drugs and Drug Addiction, EMCDDA, Pompidou Group Luxembourg Office for Official Publications of the European Communities 1997 272 p. 24 cm EMCDDA Scientific Monograph Series 1 Comunicações provenientes do seminário científico "Addiction Prevalence Estimation: Methods and Research Strategies" que teve lugar em Estrasburgo, França, entre 10 e 14 de Junho de 1996. Acknowledgments. General introduction (Richard Hartnoll). Part I - Science and policy: Introduction (Gerry V. Stimson). Chapter 1 - Estimating the scale and nature of drug problems: the relationship between science, policy and drugs strategy (Gerry V. Stimson; Ali Judd). Chapter 2 - The relationship between drug use prevalence estimation and policy interests (Peter D. A. Cohen). Chapter 3 - Policy makers and the use of prevalence data (Philip Lazarov). Part II - Case-finding methods: Introduction (Matthew Hickman). Chapter 4 - Estimating prevalence using the case-finding method: an overview (Roland Simon). Chapter 5 - A case-finding study to estimate the prevalence of heroin users in Navarra, Spain (Conchi Moreno Iribas; Mikel Urtiaga Dominguez). Chapter 6 - Problems of definition and other aspects of case-finding: the Swedish nationwide studies (Börje Olsson). Chapter 7 - Local prevalence estimation: can an inner-city prevalence survey produce useful information? (Paul Griffiths; Michael Farrell; Samantha Howes). Part III - Capture-recapture methods: Introduction (Martin Frischer). Chapter 8 - Estimating the prevalence of drug use using the capture-recapture method: an overview (Antònia Domingo-Salvany). Chapter 9 - Capture-recapture methodology: lessons from studies of animal populations (Clive Richardson). Chapter 10 - A capture-recapture study to estimate the size of the addict population in Toulose, France (Pierre-Yves; Geneviève Chêne). Chapter 11 - More complex capture-recapture models: an illustrative case study using data from Glasgow, Scotland (Martin Frischer). Part IV - Multiplier methods: Introduction (Colin Taylor). Chapter 12 - Estimating the prevalence of drug abuse using the mortality multiplier method: an overview (Martin Frischer). Chapter 13 - Determining the number of drug-related deaths (Klaus Puschel). Chapter 14 - Establishing mortality rates from cohort data (Marina Davoli). Chapter 15 - Drug-related deaths as an indirect indicator, based on the Danish experience (Kenrik Saelan). Part V - Nomination methods: Introduction (Martin Frischer). Chapter 16 - Estimating the prevalence of drug use using nomination techniques: an overview (Colin Taylor). Chapter 17 - The tip of the iceberg: snowball sampling and nomination techniques, the experience of Dutch studies (Dirk J. Korf). Part VI - Combining estimation methods and system dynamics models (Ludwig Kraus). Chapter 19 - Comparison of different estimation methods in the Netherlands (Dirk J. Korf). Chapter 20 - Case finding, capture-recapture and double counting: a Berlin case study (Wolf Kirschner). Chapter 21 - Difficulties in estimating prevalence in Budapest (Zsuzsanna Elekes). Chapter 22 - Comparison of different estimation methods in Poland (Janusz Sieroslawski; Antoni Zielínski). Chapter 23 - Comparison of key informant and multiplier estimates in Slovenia (Dusan Nolimal). Chapter 24 - Cross-validating at local level (Richard Hartnoll). General conclusions (Richard Hartnoll). Contributors. DROGA 228142 PREVENÇÃO DA TOXICODEPENDÊNCIA 103892 ESTATÍSTICAS SOBRE DROGA 344136 OEDT 321506 COMUNIDADE EUROPEIA 220383 EUROPA 326972 EUROPEAN MONITORING CENTRE FOR DRUGS AND DRUG ADDICTION 351987 Oferta 0 PJ_19_000000000000000_D_61 2022-06-06 PJ28025 425412 PJ PJ PJ128025 PJ19.D.61 2022-06-06 0 MO Oferta